Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Overview
  • Published:

Collaboration between basic science researchers and bariatric surgeons is a win/win proposition: view from the chair

Abstract

Bariatric surgery in humans offers a window of opportunity to further our understanding of obesity and associated diseases. In the morbidly obese subjects, physiological disturbances are amplified and their extreme manifestations are more easily measured. The significant and predictable effects of bariatric surgery present a striking contrast to preoperative morbid conditions. The bariatric procedure is a reproducible therapy occurring at a precise time point; this facilitates the recording of preoperative and postoperative parameters over a short period of time, with some assurance that the contrasted conditions will confirm or disprove hypotheses with manageable numbers of subjects, thus providing an economy of means and efforts in a shorter time frame.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 1999; 84: 1513–1517.

    Article  CAS  Google Scholar 

  2. Kral JG, Thung SN, Biron S, Hould FS, Lebel S, Marceau S et al. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery 2004; 135: 48–58.

    Article  Google Scholar 

  3. Dixon JB . Surgical treatment for obesity and its impact on non-alcoholic steatohepatitis. Clin Liver Dis 2007; 11: 141–154.

    Article  Google Scholar 

  4. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122: 248–256.e5.

    Article  Google Scholar 

  5. Laferrère B, Teixeira J, McGinty J, Tran H, Egger JR, Colarusso A et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2008; 93: 2479–2485.

    Article  Google Scholar 

  6. Dixon JB, O’Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S et al. Adjustable gastric banding and conventional therapy for type 2 diabetes. JAMA 2008; 299: 316–323.

    CAS  Google Scholar 

  7. Greenburg DL, Lettieri CJ, Eliasson AH . Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis. Am J Med 2009; 122: 535–542.

    Article  Google Scholar 

  8. Simard B, Turcotte T, Marceau P, Biron S, Hould FS, Lebel S et al. Asthma and sleep apnea in patients with morbid obesity: outcome after bariatric surgery. Obes Surg 2004; 14: 1381–1388.

    Article  Google Scholar 

  9. Maniscalco M, Zedda A, Faraone S, Cerbone MR, Cristiano S, Giardiello C et al. Weight loss and asthma control in severely obese asthmatic females. Respir Med 2008; 102: 102–108.

    Article  Google Scholar 

  10. Bueter M, Ahmed A, Ashrafian H, le Roux CW . Bariatric surgery and hypertension. Surg Obes Relat Dis 2009; 5: 615–620.

    Article  Google Scholar 

  11. Poitou C, Lacorte JM, Coupaye M, Bertrais S, Bedel JF, Lafon N et al. Relationship between single nucleotide polymorphisms in leptin, IL6 and adiponectin genes and their circulating product in morbidly obese subjects before and after gastric banding surgery. Obes Surg 2005; 15: 11–23.

    Article  Google Scholar 

  12. Dubern B, Bisbis S, Talbaoui H, Le Beyec J, Tounian P, Lacorte JM et al. Homozygous null mutation of the melanocortin-4 receptor and severe early-onset obesity. J Pediatr 2007; 150: 613–617.e1.

    Article  CAS  Google Scholar 

  13. Baddeley RM . An epilogue to jejunoileal bypass. World J Surg 1985; 9: 842–849.

    Article  CAS  Google Scholar 

  14. Svenheden KE, Akesson LA, Holmdahl C, Näslund I . Staple disruption in vertical banded gastroplasty. Obes Surg 1997; 7: 136–138.

    Article  CAS  Google Scholar 

  15. Mason EE, Ito C . Gastric bypass in obesity. Surg Clin N Am 1967; 47: 1345–1351.

    Article  CAS  Google Scholar 

  16. Johnston D, Dachtler J, Sue-Ling HM, King RF, Martin G . The Magenstrasse and Mill operation for morbid obesity. Obes Surg 2003; 13: 10–16.

    Article  Google Scholar 

  17. Marceau P, Biron S, Bourque RA, Potvin M, Hould FS, Simard S . Biliopancreatic diversion with a new type of gastrectomy. Obes Surg 1993; 3: 29–35.

    Article  CAS  Google Scholar 

  18. Hess DS, Hess DW . Biliopancreatic diversion with a duodenal switch. Obes Surg 1998; 8: 267–282.

    Article  CAS  Google Scholar 

  19. Regan J, Inabnet W, Gagner M, Pomp A . Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg 2003; 13: 861–864.

    Article  CAS  Google Scholar 

  20. Gagner M, Deitel M, Kalberer TL, Erickson AL, Crosby RD . The Second International Consensus Summit for Sleeve Gastrectomy, March 19–21, 2009. Surg Obes Relat Dis 2009; 5: 476–485.

    Article  Google Scholar 

  21. Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V . Bilio-pancreatic bypass for obesity: 1. An experimental study in dogs. Br J Surg 1979; 66: 613–617.

    Article  CAS  Google Scholar 

  22. Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V . Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg 1979; 66: 618–620.

    Article  CAS  Google Scholar 

  23. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 223: 339–352.

    Article  Google Scholar 

  24. Brown W, Korin A, Burton P, O’Brien PE . Laparoscopic adjustable gastric banding. Aust Fam Physician 2009; 38: 972–976.

    PubMed  Google Scholar 

  25. Burton P, Brown W, Laurie C, Richards M, Hebbard G, O’Brien P . Effects of gastric band adjustments on intraluminal pressure. Obes Surg 2009; 19: 1508–1514.

    Article  Google Scholar 

  26. Burton PR, Brown WA, Laurie C, Korin A, Yap K, Richards M et al. Pathophysiology of laparoscopic adjustable gastric bands: analysis and classification using high-resolution video manometry and a stress barium protocol. Obes Surg 2010; 20: 19–29.

    Article  Google Scholar 

  27. Burton PR, Brown W, Laurie C, Richards M, Afkari S, Yap K et al. The effect of laparoscopic adjustable gastric bands on esophageal motility and the gastroesophageal junction: analysis using high-resolution video manometry. Obes Surg 2009; 19: 905–914.

    Article  Google Scholar 

  28. Burton P, Brown W, Laurie C, Hebbard G, O’Brien P . Criteria for assessing esophageal motility in laparoscopic adjustable gastric band patients: the importance of the lower esophageal contractile segment. Obes Surg 2010; 20: 316–325.

    Article  Google Scholar 

  29. Burton P, Brown W, Laurie C, Hebbard G, O’Brien P . Mechanisms of bolus clearance in patients with laparoscopic adjustable gastric bands. Obes Surg 2010; 20: 1265–1272.

    Article  Google Scholar 

  30. Burton PR, Brown W, Laurie C, Lee M, Korin A, Anderson M et al. Outcomes, satiety, and adverse upper gastrointestinal symptoms following laparoscopic adjustable gastric banding. Obes Surg 2011; 21: 574–581.

    Article  Google Scholar 

  31. Burton PR, Yap K, Brown WA, Laurie C, O’Donnell M, Hebbard G et al. Effects of adjustable gastric bands on gastric emptying, supra- and infraband transit and satiety: a randomized double-blind crossover trial using a new technique of band visualization. Obes Surg 2010; 20: 1690–1697.

    Article  Google Scholar 

  32. Emerging Technologies and Clinical Issues Committees of the ASMBS. American Society for Metabolic and Bariatric Surgery Position Statement on emerging endosurgical interventions for treatment of obesity. Surg Obes Relat Dis 2009; 5: 297–298.

    Article  Google Scholar 

  33. ASMBS Clinical Issues Committee. ASMBS guideline on the prevention and detection of gastrointestinal leak after gastric bypass including the role of imaging and surgical exploration. Surg Obes Relat Dis 2009; 5: 293–296.

    Article  Google Scholar 

  34. Livingston EH . Surgical volume impacts bariatric surgery mortality: a case for bariatric surgery centers of excellence. Surgery 2010; 147: 751–753.

    Article  Google Scholar 

  35. Pratt GM, Learn CA, Hughes GD, Clark BL, Warthen M, Pories W . Demographics and outcomes at American Society for Metabolic and Bariatric Surgery Centers of Excellence. Surg Endosc 2009; 23: 795–799.

    Article  Google Scholar 

  36. DeMaria EJ, Winegar DA, Pate VW, Hutcher NE, Ponce J, Pories WJ . Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database. Ann Surg 2010; 252: 559–567.

    PubMed  Google Scholar 

  37. Belle S, LABS Consortium. The NIDDK Bariatric Surgery Clinical Research Consortium (LABS). Surg Obes Relat Dis 2005; 1: 145–147.

    Article  Google Scholar 

  38. Belle SH, Berk PD, Courcoulas AP, Flum DR, Miles CW, Mitchell JE et al. Safety and efficacy of bariatric surgery: longitudinal assessment of bariatric surgery. Surg Obes Relat Dis 2007; 3: 116–126.

    Article  Google Scholar 

  39. Schauer PR, Ikramuddin S . Laparoscopic surgery for morbid obesity. Surg Clin N Am 2001; 81: 1145–1179.

    Article  CAS  Google Scholar 

  40. Rubino F, Kaplan LM, Schauer PR, Cummings DE, Diabetes Surgery Summit Delegates. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg 2010; 251: 406–408.

    Article  Google Scholar 

  41. Kashyap SR, Bhatt DL, Schauer PR, STAMPEDE Investigators. Bariatric surgery vs. advanced practice medical management in the treatment of type 2 diabetes mellitus: rationale and design of the Surgical Therapy and Medications Potentially Eradicate Diabetes Efficiently trial (STAMPEDE). Diabetes Obes Metab 2010; 12: 452–454.

    Article  Google Scholar 

  42. Laferrere B, Abraham C, Russell CD, Bowers CY . Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men. J Clin Endocrinol Metab 2005; 90: 611–614.

    Article  CAS  Google Scholar 

  43. Laferrere B, Hart AB, Bowers CY . Obese subjects respond to the stimulatory effect of the ghrelin agonist growth hormone-releasing peptide-2 on food intake. Obesity (Silver Spring) 2006; 14: 1056–1063.

    Article  CAS  Google Scholar 

  44. Lee H, Te C, Koshy S, Teixeira JA, Pi-Sunyer FX, LaferrËre B . Does ghrelin really matter after bariatric surgery? Surg Obes Relat Dis 2006; 2: 538–548.

    Article  Google Scholar 

  45. Laferrère B, Heshka S, Wang K, Khan Y, McGinty J, Teixeira J et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 2007; 30: 1709–1716.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F-S Hould.

Ethics declarations

Competing interests

The author declares no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hould, FS. Collaboration between basic science researchers and bariatric surgeons is a win/win proposition: view from the chair. Int J Obes 35 (Suppl 3), S3–S6 (2011). https://doi.org/10.1038/ijo.2011.140

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2011.140

Keywords

Search

Quick links